EcoR1 Capital Fund L.P. 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

EcoR1 Capital Fund L.P. 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-03-09
2:31 pm
Unchanged		2021-03-0413GOvid Therapeutics Inc.
OVID		EcoR1 Capital Fund L.P.6,082,200
9.600%		0
(Unchanged)		Filing
2021-03-09
1:19 pm
Purchase		2020-03-0413GOvid Therapeutics Inc.
OVID		EcoR1 Capital Fund L.P.6,082,200
9.600%		6,082,200increase
(New Position)		Filing